Menlo Park, CA, United States of America

Stephen Wilson Turner

This inventor holds 190 USPTO granted patents and 21 published patent applications, plus 12 CIPO patents and 36 EPO patents, primarily in Nucleic Acid Sequencing (CPC class C12Q1-6869). Top assignees: Pacific Biosciences of California, Inc., Cornell University, Juniper Networks, Inc.. Active years: 2004-2026.

USPTO Granted Patents = 190 

% Patents Active = 92.6

 

 

Average Co-Inventor Count = 3.3

ph-index = 54

Forward Citations = 10,042(Granted Patents)

Forward Citations (Not Self Cited) = 8,465(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Palo Alto, CA (US) (2007)
  • Ithaca, NY (US) (2004 - 2011)
  • Menlo Park, CA (US) (2005 - 2020)
  • Kirkland, WA (US) (2015 - 2020)
  • Eugene, OR (US) (2019 - 2023)
  • Seattle, WA (US) (2015 - 2024)

Company Filing History:


Years Active: 2004-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Sequencing
Optical Analytical Devices
Single-Molecule Detection
Integrated Illumination
NanoFET Sequencing
Nanopore Sequencing
Molecule Delivery
Kinetic Signatures
Genome Assembly
Modified Nucleic Acids
Electrode Pairs
Enzyme Translocation
190 patents (USPTO):Explore Patents

Title: The Innovative Journey of Stephen Wilson Turner

Introduction:

Stephen Wilson Turner, a prolific inventor based in Menlo Park, CA (US), has made significant contributions in the field of nucleic acid sequencing technologies. With an impressive portfolio of 168 patents, Turner is recognized for his groundbreaking work in the characterization of modified nucleic acids.

Latest Patents:

Among his latest patents is the groundbreaking "Classification of nucleic acid templates" innovation. Turner's method, compositions, and systems offer a unique approach to identifying modified nucleotides within nucleic acid sequences. These modifications include chemically and enzymatically modified bases, abasic sites, non-natural bases, secondary structures, and agents bound to a template nucleic acid.

Another notable patent is "Systems and methods for selectively addressing sparsely arranged electronic measurement devices," which showcases Turner's expertise in circuit design. This invention involves nano-electronic measurement devices on a substrate with specialized functionality and interactions for precise electronic measurements.

Career Highlights:

Turner has held pivotal roles in renowned companies such as Pacific Biosciences of California, Inc. (now known as PacBio) and Juniper Networks, Inc., where he has spearheaded cutting-edge research and development initiatives. His innovative spirit and technical prowess have been instrumental in shaping the future of biotechnology and electronics industries.

Collaborations:

Throughout his career, Turner has collaborated with esteemed professionals in the field, including Jonas Korlach and Paul M Lundquist. These partnerships have led to synergistic efforts in advancing scientific research, fostering a culture of innovation, and driving technological progress.

Conclusion:

Stephen Wilson Turner's remarkable journey as an inventor is characterized by a relentless pursuit of excellence and a commitment to pushing the boundaries of scientific exploration. His pioneering patents and collaborative endeavors stand as a testament to his profound impact on the fields of nucleic acid sequencing and circuit design. Turner's visionary contributions continue to inspire future generations of innovators worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…